SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-23-000086
Filing Date
2023-11-09
Accepted
2023-11-09 17:03:00
Documents
71
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20230930.htm   iXBRL 10-Q 1311546
2 EX-31.1 lgnd_93023exhibit311.htm EX-31.1 15161
3 EX-31.2 lgnd_93023exhibit312.htm EX-31.2 15432
4 EX-32.1 lgnd_93023exhibit321.htm EX-32.1 11172
10 lgnd-20230930_g1.jpg GRAPHIC 51754
  Complete submission text file 0000886163-23-000086.txt   8516646

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20230930.xsd EX-101.SCH 60350
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20230930_cal.xml EX-101.CAL 103077
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20230930_def.xml EX-101.DEF 396244
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20230930_lab.xml EX-101.LAB 874218
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20230930_pre.xml EX-101.PRE 559102
65 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20230930_htm.xml XML 1143064
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 231393597
SIC: 2834 Pharmaceutical Preparations